Free press releases distribution network?

Agency / Source: BioNet-Asia Co., Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



BioNet-Asia to License Recombinant Pertussis Strain - BioNet-Asia Co., Ltd, announced the signature with a China-based company of a binding letter of intent to license a Bordetella pertussis strain, genetically modified to express antigens - BioNet-Asia.com
BioNet-Asia to License Recombinant Pertussis Strain

 

PRZOOM - /newswire/ - Bangkok, Thailand, 2012/01/13 - BioNet-Asia Co., Ltd, announced the signature with a China-based company of a binding letter of intent to license a Bordetella pertussis strain, genetically modified to express antigens - BioNet-Asia.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BioNet-Asia Co., Ltd, a vaccine-focused biotech company based in Thailand has announced today the signature with a China-based company of a binding letter of intent to license a Bordetella pertussis strain, genetically modified to express antigens that can be used in the development of acellular pertussis-based vaccines.

Acellular Pertussis Vaccines are now routinely and successfully used to prevent whooping cough disease, in Western Europe, North America, Japan and Korea but not in the emerging countries because of the high cost.

The advantages of the recombinant pertussis strain producing very high yields of inactivated pertussis toxins enable the production of a recombinant Acellular Pertussis Vaccine to be affordable in China and other developing countries.

Mr Vitoon Vonghangool, Managing Director of BioNet-Asia said “This is an important milestone because it is the outcome of years of research and development in Thailand.
Our company has been heavily affected by the floods in October 2011 and it was important to find a partner interested in our recombinant pertussis strain. We expect to receive double-digit million dollars over a period of 10 years followed by royalties. Upfront payments are expected within this year and will be used to reconstruct our facilities.”
Dr Pham Hong Thai, Managing Director of BioNet-Asia concluded that “The agreement will be signed within a couple of months and we are also in discussion with some vaccine manufacturers for collaboration on recombinant acellular pertussis based vaccines.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: BioNet-Asia Co., Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BioNet-Asia to License Recombinant Pertussis Strain

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: BioNet-Asia.com 
+662 361 8110 info[.]bionet-asia.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BioNet-Asia Co., Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From BioNet-Asia Co., Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com

Visit  RightITnow Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today